Cargando…

A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers

OBJECTIVE: Hepatocellular carcinoma (HCC) development among hepatitis B surface antigen (HBsAg) carriers shows gender disparity, influenced by underlying liver diseases that display variations in laboratory tests. We aimed to construct a risk-stratified HCC prediction model for HBsAg-positive male a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuting, Wang, Minjie, Li, He, Chen, Kun, Zeng, Hongmei, Bi, Xinyu, Zhu, Zheng, Jiao, Yuchen, Wang, Yong, Zhu, Jian, Zhao, Hui, Liu, Xiang, Dai, Chunyun, Fan, Chunsun, Zhao, Can, Guo, Deyin, Zhao, Hong, Zhou, Jianguo, Wang, Dongmei, Wu, Zhiyuan, Zhao, Xinming, Cui, Wei, Zhang, Xuehong, Cai, Jianqiang, Chen, Wanqing, Qu, Chunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286891/
https://www.ncbi.nlm.nih.gov/pubmed/34321832
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.07
_version_ 1783723807810256896
author Wang, Yuting
Wang, Minjie
Li, He
Chen, Kun
Zeng, Hongmei
Bi, Xinyu
Zhu, Zheng
Jiao, Yuchen
Wang, Yong
Zhu, Jian
Zhao, Hui
Liu, Xiang
Dai, Chunyun
Fan, Chunsun
Zhao, Can
Guo, Deyin
Zhao, Hong
Zhou, Jianguo
Wang, Dongmei
Wu, Zhiyuan
Zhao, Xinming
Cui, Wei
Zhang, Xuehong
Cai, Jianqiang
Chen, Wanqing
Qu, Chunfeng
author_facet Wang, Yuting
Wang, Minjie
Li, He
Chen, Kun
Zeng, Hongmei
Bi, Xinyu
Zhu, Zheng
Jiao, Yuchen
Wang, Yong
Zhu, Jian
Zhao, Hui
Liu, Xiang
Dai, Chunyun
Fan, Chunsun
Zhao, Can
Guo, Deyin
Zhao, Hong
Zhou, Jianguo
Wang, Dongmei
Wu, Zhiyuan
Zhao, Xinming
Cui, Wei
Zhang, Xuehong
Cai, Jianqiang
Chen, Wanqing
Qu, Chunfeng
author_sort Wang, Yuting
collection PubMed
description OBJECTIVE: Hepatocellular carcinoma (HCC) development among hepatitis B surface antigen (HBsAg) carriers shows gender disparity, influenced by underlying liver diseases that display variations in laboratory tests. We aimed to construct a risk-stratified HCC prediction model for HBsAg-positive male adults. METHODS: HBsAg-positive males of 35−69 years old (N=6,153) were included from a multi-center population-based liver cancer screening study. Randomly, three centers were set as training, the other three centers as validation. Within 2 years since initiation, we administrated at least two rounds of HCC screening using B-ultrasonography and α-fetoprotein (AFP). We used logistic regression models to determine potential risk factors, built and examined the operating characteristics of a point-based algorithm for HCC risk prediction. RESULTS: With 2 years of follow-up, 302 HCC cases were diagnosed. A male-ABCD algorithm was constructed including participant’s age, blood levels of GGT (γ-glutamyl-transpeptidase), counts of platelets, white cells, concentration of DCP (des-γ-carboxy-prothrombin) and AFP, with scores ranging from 0 to 18.3. The area under receiver operating characteristic was 0.91 (0.90−0.93), larger than existing models. At 1.5 points of risk score, 26.10% of the participants in training cohort and 14.94% in validation cohort were recognized at low risk, with sensitivity of identifying HCC remained 100%. At 2.5 points, 46.51% of the participants in training cohort and 33.68% in validation cohort were recognized at low risk with 99.06% and 97.78% of sensitivity, respectively. At 4.5 points, only 20.86% of participants in training cohort and 23.73% in validation cohort were recognized at high risk, with positive prediction value of 22.85% and 12.35%, respectively. CONCLUSIONS: Male-ABCD algorithm identified individual’s risk for HCC occurrence within short term for their HCC precision surveillance.
format Online
Article
Text
id pubmed-8286891
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-82868912021-07-27 A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers Wang, Yuting Wang, Minjie Li, He Chen, Kun Zeng, Hongmei Bi, Xinyu Zhu, Zheng Jiao, Yuchen Wang, Yong Zhu, Jian Zhao, Hui Liu, Xiang Dai, Chunyun Fan, Chunsun Zhao, Can Guo, Deyin Zhao, Hong Zhou, Jianguo Wang, Dongmei Wu, Zhiyuan Zhao, Xinming Cui, Wei Zhang, Xuehong Cai, Jianqiang Chen, Wanqing Qu, Chunfeng Chin J Cancer Res Original Article OBJECTIVE: Hepatocellular carcinoma (HCC) development among hepatitis B surface antigen (HBsAg) carriers shows gender disparity, influenced by underlying liver diseases that display variations in laboratory tests. We aimed to construct a risk-stratified HCC prediction model for HBsAg-positive male adults. METHODS: HBsAg-positive males of 35−69 years old (N=6,153) were included from a multi-center population-based liver cancer screening study. Randomly, three centers were set as training, the other three centers as validation. Within 2 years since initiation, we administrated at least two rounds of HCC screening using B-ultrasonography and α-fetoprotein (AFP). We used logistic regression models to determine potential risk factors, built and examined the operating characteristics of a point-based algorithm for HCC risk prediction. RESULTS: With 2 years of follow-up, 302 HCC cases were diagnosed. A male-ABCD algorithm was constructed including participant’s age, blood levels of GGT (γ-glutamyl-transpeptidase), counts of platelets, white cells, concentration of DCP (des-γ-carboxy-prothrombin) and AFP, with scores ranging from 0 to 18.3. The area under receiver operating characteristic was 0.91 (0.90−0.93), larger than existing models. At 1.5 points of risk score, 26.10% of the participants in training cohort and 14.94% in validation cohort were recognized at low risk, with sensitivity of identifying HCC remained 100%. At 2.5 points, 46.51% of the participants in training cohort and 33.68% in validation cohort were recognized at low risk with 99.06% and 97.78% of sensitivity, respectively. At 4.5 points, only 20.86% of participants in training cohort and 23.73% in validation cohort were recognized at high risk, with positive prediction value of 22.85% and 12.35%, respectively. CONCLUSIONS: Male-ABCD algorithm identified individual’s risk for HCC occurrence within short term for their HCC precision surveillance. AME Publishing Company 2021-06-30 /pmc/articles/PMC8286891/ /pubmed/34321832 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.07 Text en Copyright ©2021Chinese Journal of Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Original Article
Wang, Yuting
Wang, Minjie
Li, He
Chen, Kun
Zeng, Hongmei
Bi, Xinyu
Zhu, Zheng
Jiao, Yuchen
Wang, Yong
Zhu, Jian
Zhao, Hui
Liu, Xiang
Dai, Chunyun
Fan, Chunsun
Zhao, Can
Guo, Deyin
Zhao, Hong
Zhou, Jianguo
Wang, Dongmei
Wu, Zhiyuan
Zhao, Xinming
Cui, Wei
Zhang, Xuehong
Cai, Jianqiang
Chen, Wanqing
Qu, Chunfeng
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title_full A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title_fullStr A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title_full_unstemmed A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title_short A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers
title_sort male-abcd algorithm for hepatocellular carcinoma risk prediction in hbsag carriers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286891/
https://www.ncbi.nlm.nih.gov/pubmed/34321832
http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.07
work_keys_str_mv AT wangyuting amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangminjie amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT lihe amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT chenkun amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zenghongmei amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT bixinyu amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhuzheng amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT jiaoyuchen amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangyong amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhujian amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaohui amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT liuxiang amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT daichunyun amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT fanchunsun amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaocan amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT guodeyin amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaohong amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhoujianguo amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangdongmei amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wuzhiyuan amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaoxinming amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT cuiwei amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhangxuehong amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT caijianqiang amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT chenwanqing amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT quchunfeng amaleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangyuting maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangminjie maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT lihe maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT chenkun maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zenghongmei maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT bixinyu maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhuzheng maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT jiaoyuchen maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangyong maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhujian maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaohui maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT liuxiang maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT daichunyun maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT fanchunsun maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaocan maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT guodeyin maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaohong maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhoujianguo maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wangdongmei maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT wuzhiyuan maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhaoxinming maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT cuiwei maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT zhangxuehong maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT caijianqiang maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT chenwanqing maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers
AT quchunfeng maleabcdalgorithmforhepatocellularcarcinomariskpredictioninhbsagcarriers